Literature DB >> 1662136

Activation of O2(-)-generating oxidase in an heterologous cell-free system derived from Epstein-Barr-virus-transformed human B lymphocytes and bovine neutrophils. Application to the study of defects in cytosolic factors in chronic granulomatous disease.

L Cohen-Tanugi1, F Morel, M C Pilloud-Dagher, J M Seigneurin, P Francois, M Bost, P V Vignais.   

Abstract

Epstein-Barr-virus-transformed human B lymphocytes (EBV B lymphocytes) stimulated by 4 beta-phorbol 12-myristate 13-acetate exhibit an NADPH-dependent oxidase activity capable of generating the superoxide anion O2-, similar to, but less efficient than that of activated neutrophils. A cell-free system of oxidase activation consisting of a membrane fraction and cytosol from EBV B lymphocyte homogenate supplemented with guanosine 5'-[gamma-thio]triphosphate (GTP[S]), arachidonic acid and Mg2+ was found to be competent in the production of O2-, assessed by the superoxide-dismutase-sensitive reduction of cytochrome c in the presence of NADPH. However, cytochrome c reduction was slow and largely insensitive both to superoxide dismutase, and to iodonium biphenyl, a powerful inhibitor of the oxidase activity in neutrophils. A markedly faster reduction of cytochrome c in the presence of NADPH was obtained with a heterologous system consisting of cytosol from EBV B lymphocytes and bovine neutrophil membranes, GTP[S], arachidonic acid and Mg2+; in this system, reduction of cytochrome c was totally inhibited by superoxide dismutase and iodonium biphenyl. These results show that EBV B lymphocytes contain a substantial amount of cytosolic factors of oxidase activation, and that the limiting factors for O2- production in B lymphocytes are the membrane components of the oxidase complex. The heterologous system of EBV B lymphocyte cytosol and bovine neutrophil membranes provided a rapid and convenient method to diagnose cytosolic defects in autosomal forms of chronic granulomatous disease. In addition, it might be a useful tool to explore the mechanism of action of the cytosolic factors in oxidase activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662136     DOI: 10.1111/j.1432-1033.1991.tb16419.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  12 in total

1.  Voltage-activated proton currents in human lymphocytes.

Authors:  Tom Schilling; Alexander Gratopp; Thomas E DeCoursey; Claudia Eder
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

2.  Regulation of NADPH oxidase activity in phagocytes: relationship between FAD/NADPH binding and oxidase complex assembly.

Authors:  Franck Debeurme; Antoine Picciocchi; Marie-Claire Dagher; Didier Grunwald; Sylvain Beaumel; Franck Fieschi; Marie-José Stasia
Journal:  J Biol Chem       Date:  2010-08-19       Impact factor: 5.157

3.  Role of putative second transmembrane region of Nox2 protein in the structural stability and electron transfer of the phagocytic NADPH oxidase.

Authors:  Antoine Picciocchi; Franck Debeurme; Sylvain Beaumel; Marie-Claire Dagher; Didier Grunwald; Algirdas J Jesaitis; Marie-José Stasia
Journal:  J Biol Chem       Date:  2011-06-09       Impact factor: 5.157

4.  Low NADPH oxidase activity in Epstein-Barr-virus-immortalized B-lymphocytes is due to a post-transcriptional block in expression of cytochrome b558.

Authors:  M Chetty; A J Thrasher; A Abo; C M Casimir
Journal:  Biochem J       Date:  1995-02-15       Impact factor: 3.857

5.  Characterization of superoxide overproduction by the D-Loop(Nox4)-Nox2 cytochrome b(558) in phagocytes-Differential sensitivity to calcium and phosphorylation events.

Authors:  Laure Carrichon; Antoine Picciocchi; Franck Debeurme; Federica Defendi; Sylvain Beaumel; Algirdas J Jesaitis; Marie-Claire Dagher; Marie-José Stasia
Journal:  Biochim Biophys Acta       Date:  2010-08-11

6.  Characterization of six novel mutations in the CYBB gene leading to different sub-types of X-linked chronic granulomatous disease.

Authors:  Marie José Stasia; Pierre Bordigoni; Daniel Floret; Jean Paul Brion; Cécile Bost-Bru; Gérard Michel; Pierre Gatel; Denis Durant-Vital; Marie Antoinette Voelckel; Xing Jun Li; Michèle Guillot; Elisabeth Maquet; Cécile Martel; Françoise Morel
Journal:  Hum Genet       Date:  2004-11-06       Impact factor: 4.132

7.  Functional analysis of two-amino acid substitutions in gp91 phox in a patient with X-linked flavocytochrome b558-positive chronic granulomatous disease by means of transgenic PLB-985 cells.

Authors:  Clara Bionda; Xing Jun Li; Robin van Bruggen; Michel Eppink; Dirk Roos; Françoise Morel; Marie-José Stasia
Journal:  Hum Genet       Date:  2004-08-24       Impact factor: 4.132

8.  Peripheral blood progenitors as a target for genetic correction of p47phox-deficient chronic granulomatous disease.

Authors:  S Sekhsaria; J I Gallin; G F Linton; R M Mallory; R C Mulligan; H L Malech
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

9.  Functional and genetic characterization of two extremely rare cases of Williams-Beuren syndrome associated with chronic granulomatous disease.

Authors:  Marie J Stasia; Michèle Mollin; Cécile Martel; Véronique Satre; Charles Coutton; Florence Amblard; Gaëlle Vieville; Joris M van Montfrans; Jaap J Boelens; Hermine E Veenstra-Knol; Karen van Leeuwen; Martin de Boer; Jean-Paul Brion; Dirk Roos
Journal:  Eur J Hum Genet       Date:  2013-01-23       Impact factor: 4.246

10.  First report of clinical, functional, and molecular investigation of chronic granulomatous disease in nine Jordanian families.

Authors:  Faris G Bakri; Cécile Martel; Najwa Khuri-Bulos; Azmi Mahafzah; Mohammad S El-Khateeb; Adel M Al-Wahadneh; Wail A Hayajneh; Hanan A Hamamy; Elisabeth Maquet; Michelle Molin; Marie José Stasia
Journal:  J Clin Immunol       Date:  2008-09-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.